Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Moses Rodriguez

Showing results (141-150 of 251) with videos related to

Pageof 26
Sort By:
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|January 21, 2003
Interleukin-6 protects anterior horn neurons from lethal virus-induced injuryKevin D Pavelko, Charles L Howe, Kristen M Drescher, et al.
Brain Pathology (Zurich, Switzerland)|February 15, 2011
Transgenic expression of viral capsid proteins predisposes to axonal injury in a murine model of multiple sclerosisAleksandar Denic, Laurie Zoecklein, Jason Kerkvliet, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 21, 2005
Antigen-specific CD8+ T cells mediate a peptide-induced fatal syndromeAaron J Johnson, Yanice Mendez-Fernandez, Ann M Moyer, et al.
Multiple Sclerosis and Related Disorders|November 2, 2018
Acute vision loss in multiple sclerosis: Optic neuritis or central serous chorioretinopathy?Mohammad-Ali Abtahi, Alireza Dehghani, Masoud Etemadifar, et al.
Molecular Therapy. Methods & Clinical Development|May 1, 2018
An Assay that Predicts <i>In Vivo</i> Efficacy for DNA Aptamers that Stimulate Remyelination in a Mouse Model of Multiple SclerosisRobin M Heider, John A Smestad, Hernan Nicolas Lemus, et al.
Pharmaceuticals (Basel, Switzerland)|November 24, 2020
Remyelination-Promoting DNA Aptamer Conjugate Myaptavin-3064 Binds to Adult Oligodendrocytes In VitroMahboubeh Fereidan-Esfahani, Wei Ying Yue, Brandon Wilbanks, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 11, 2018
Age is a critical determinant in recovery from multiple sclerosis relapsesBrittani L Conway, Burcu Zeydan, Uğur Uygunoğlu, et al.
Archives of Neurology|April 12, 2006
Not every patient with multiple sclerosis should be treated at time of diagnosisSean J Pittock, Brian G Weinshenker, John H Noseworthy, et al.
International Journal of Radiation Oncology, Biology, Physics|September 13, 2006
Multiple sclerosis, brain radiotherapy, and risk of neurotoxicity: the Mayo Clinic experienceRobert C Miller, Daniel H Lachance, Claudia F Lucchinetti, et al.
Nucleic Acid Therapeutics|December 24, 2014
Quantitative PCR analysis of DNA aptamer pharmacokinetics in miceKatherine Perschbacher, John A Smestad, Justin P Peters, et al.
Pageof 26

Showing results (141-150 of 251) with videos related to

Sort By:
Pageof 26
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|January 21, 2003
Interleukin-6 protects anterior horn neurons from lethal virus-induced injuryKevin D Pavelko, Charles L Howe, Kristen M Drescher, et al.
Brain Pathology (Zurich, Switzerland)|February 15, 2011
Transgenic expression of viral capsid proteins predisposes to axonal injury in a murine model of multiple sclerosisAleksandar Denic, Laurie Zoecklein, Jason Kerkvliet, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 21, 2005
Antigen-specific CD8+ T cells mediate a peptide-induced fatal syndromeAaron J Johnson, Yanice Mendez-Fernandez, Ann M Moyer, et al.
Multiple Sclerosis and Related Disorders|November 2, 2018
Acute vision loss in multiple sclerosis: Optic neuritis or central serous chorioretinopathy?Mohammad-Ali Abtahi, Alireza Dehghani, Masoud Etemadifar, et al.
Molecular Therapy. Methods & Clinical Development|May 1, 2018
An Assay that Predicts <i>In Vivo</i> Efficacy for DNA Aptamers that Stimulate Remyelination in a Mouse Model of Multiple SclerosisRobin M Heider, John A Smestad, Hernan Nicolas Lemus, et al.
Pharmaceuticals (Basel, Switzerland)|November 24, 2020
Remyelination-Promoting DNA Aptamer Conjugate Myaptavin-3064 Binds to Adult Oligodendrocytes In VitroMahboubeh Fereidan-Esfahani, Wei Ying Yue, Brandon Wilbanks, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 11, 2018
Age is a critical determinant in recovery from multiple sclerosis relapsesBrittani L Conway, Burcu Zeydan, Uğur Uygunoğlu, et al.
Archives of Neurology|April 12, 2006
Not every patient with multiple sclerosis should be treated at time of diagnosisSean J Pittock, Brian G Weinshenker, John H Noseworthy, et al.
International Journal of Radiation Oncology, Biology, Physics|September 13, 2006
Multiple sclerosis, brain radiotherapy, and risk of neurotoxicity: the Mayo Clinic experienceRobert C Miller, Daniel H Lachance, Claudia F Lucchinetti, et al.
Nucleic Acid Therapeutics|December 24, 2014
Quantitative PCR analysis of DNA aptamer pharmacokinetics in miceKatherine Perschbacher, John A Smestad, Justin P Peters, et al.
Pageof 26